STLNW Starling Oncology, Inc. - Warrant

NAS · US · Healthcare · Health Care Equipment & Supplies · starlingoncology.com

0.0397USD-20.12%Mkt Cap: —P/E: —4d ago

Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company of…

Industry Peers

Health Care Equipment & Supplies

Screen all

TEVO

Tevano Systems Holdings Inc.

$437.4KUSD

0IFR

ChronoScale Holdings Corporation

—

SBCWW

SBC Medical Group Holdings Incorporated - Warrants

—

LUCYW

Innovative Eyewear, Inc. - Warrants

Key Statistics

Company

Market Cap—

Enterprise Value—

Revenue (TTM)587.24M USD

Gross Profit92.17M USD

Net Income (TTM)-30.56M USD

Revenue/Share5.81 USD

Last Price0.0397 USD

Fiscal Year End—

MR Quarter—

Employees641

CountryUS

SectorHealthcare

IndustryHealth Care Equipment & Supplies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B-0.16

EPS (TTM)—

EPS (Forward)—

52W Range

0.020240% of range0.0690

52W High0.0690 USD

52W Low0.0202 USD

Profitability

Gross Margin15.69%

Oper. Margin-2.86%

EBITDA Margin-3.28%

Profit Margin-6.18%

ROE—

ROA-9.65%

Growth

Revenue Growth34.60%

Earnings Growth—

Cash Flow & Leverage

Operating CF328.00K USD

CapEx (TTM)—

FCF Margin1.46%

FCF Yield—

Net Debt63.70M USD

Net Debt/EBITDA-3.30

Balance Sheet

Debt/Equity—

Current Ratio1.36

Quick Ratio1.14

Book Value/Sh-0.25 USD

Cash/Share0.40 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.—

Float88.89M

Insiders—

Institutions—

Technical

SMA 50—

SMA 200—

Beta0.44

S&P 52W Chg14.58%

Avg Vol (30d)5.00K

Avg Vol (10d)—

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—